Karthik Shekhar is John F. Heil Jr. Professor in the chemical and biomolecular engineering department at the University of California, Berkeley. His laboratory is cross-affiliated with neuroscience, vision science and the Lawrence Berkeley Laboratory. His interests are at the interface of neuroscience, genomics and applied mathematics, and his group uses both experimental and computational approaches to understand how diverse types of neurons in the brain develop and evolve, and how they become selectively vulnerable during diseases. He has received the NIH Pathway to Independence Award, the Hellman Fellowship and the McKnight Fellowship in Neuroscience. He also recently received the Donald E. Noyce Prize for Excellence in Undergraduate Teaching.
Karthik Shekhar
Assistant professor of chemical and biomolecular engineering
University of California, Berkeley
From this contributor
Building a brain: How does it generate its exquisite diversity of cells?
High-throughput technologies have revealed new insights into how the brain develops. But a truly comprehensive map of neurodevelopment requires further advances.
Building a brain: How does it generate its exquisite diversity of cells?
Explore more from The Transmitter
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.